HOME >> BIOLOGY >> NEWS
Device liberates quadriplegic from ventilator

CLEVELAND -- With the help of researchers and physicians from Case Western Reserve University and University Hospitals of Cleveland, Tom Conlan can take a breath and smell. For most of us, that doesn't seem like a big deal, but Conlan is paralyzed from the neck down and cannot breath without help.

For people in his condition, that help comes from a ventilator, a mechanical pump that connects into the throat with a plastic hose. The ventilator fills his lungs with air, bypassing the mouth and nose and depriving him of the sense of smell. And he breathes when the machine forces him to take a breath.

Conlan, 36, of Valley City, Ohio, is now the first person in the world to have a revolutionary electrical stimulation device that activates the phrenic nerve in his diaphragm, the large breathing muscle. The device gets him off the ventilator and allows him to breathe through his nose and mouth. Now a small pleasure that most of us take for granted is a major change for him.

"I can smell everything," he said.

The device was developed from 20 years of research in electrical stimulation of muscles in the laboratory of Thomas Mortimer, professor of biomedical engineering at CWRU. Mortimer and his colleagues also developed computer software to map the nerves in the diaphragm, essential to putting the electrodes in the correct spots.

The device was implanted last March in a minimally invasive surgical procedure led at UHC by Raymond Onders, a CWRU assistant professor of surgery. Working through a laparascope, Onders placed electrodes in Conlan's diaphragm. Conlan's medical team also includes Tom Stellato, CWRU professor of surgery and UHC chief of general surgery, and Anthony DiMarco, CWRU professor of medicine and UHC pulmonologist.

The development of the electrical stimulation device was a team effort by biomedical engineers and physician-researchers at CWRU, the Louis Stokes Cleveland VA Medical Center, UHC, and MetroHealth Medical Center.

Di
'"/>

Contact: George Stamatis
gxs18@po.cwru.edu
216-368-3635
Case Western Reserve University
13-May-2001


Page: 1 2 3

Related biology news :

1. Device that rapidly detects nerve agents named one of greatest army inventions for 2003
2. Tiny tango: Device sorts microscopic particles with speed and precision
3. Device detects, traps and deactivates airborne viruses and bacteria
4. Growing Up On Their Own: Smart Plastics Organize Themselves Into Useful Optical Devices
5. New Rehabilitative Device Combines Form And Function For Children With Mobility Impairments
6. New Device Brightens Recycling Efforts
7. New Device To Alleviate Distress Caused By Tinnitus
8. University of Kentucky Neuroscientist Develops Unique Device For Treatment Of Brain Tumors
9. Penn Researchers Invent Worlds First Device To Rapidly Assess Lung Function
10. Circulatory Device -- A Bridge To Recovery For Heart Failure?
11. UPMC Reports On New Liver Assist Device

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Device liberates quadriplegic from ventilator

(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... PMG Research, Benchmark Research, and ... formation of VaxCorps, a network of highly experienced, ... conduct of vaccine trials in healthy adult, elderly, ... successfully conducted over 500 phase I-III vaccine clinical ... influenza as well as a vast array of ...
(Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... that its subsidiary corporation, NuGene BioPharma, Inc. has ... board. Dr. Guan is an internationally ... After finishing his college education at Peking University, ... his Ph.D. degree from the University of North ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... 30, 2015  Spherix Incorporated (Nasdaq: SPEX ... fostering and monetization of intellectual property, today provided ... 3:13-cv-03494-M and  Spherix v. Uniden , Case No. ... for the Northern District of Texas ... v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
Cached News: